PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Regional Center of Pharmacovigilance, Pharmacology Department, Cochin Hospital, AP-HP Centre-Université de Paris.\', \'Pharmacology Department, Cochin Hospital, AP-HP Centre-Université de Paris.\', \'Pneumology Department, Cochin Hospital, AP-HP Centre-Université de Paris.\', \'Internal Medicine Department, Cochin Hospital, AP-HP Centre-Université de Paris.\', \'Antimicrobial Stewardship Team, Cochin Hospital, AP-HP Centre-Université de Paris; and.\', \'Pharmacy Department, Cochin Hospital, AP-HP Centre-Université de Paris, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/FTD.0000000000000838
?:hasPublicationType
?:journal
  • Therapeutic drug monitoring
is ?:pmid of
?:pmid
?:pmid
  • 33230045
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.656
?:rankingScore_hIndex
  • 84
is ?:relation_isRelatedTo_publication of
?:title
  • Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33230045>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33230045>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all